News & Analysis on Clinical Trial Services & Contract Research And Development
Schering-Plough has entered into an agreement with Oncomethylome Sciences (OMS), which allows the pharma giants to use OMS Pharmacogenomic technology to study MGMT methylation status in brain cancer patients.
The Association of the British Pharmaceutial Industry (ABPI) has revealed a new code of practice for the pharmaceutical industry, with an emphasis on patient safety especially material detailing information about reporting adverse drug reactions.
Vasogen announced preclinical data this week, demonstrating the ability of its lead drug candidate to modulate key signalling pathways associated with inflammation, demonstrating therapeutic potential in a range of neurological disorders.
Millipore Corporation today announced two tangential flow filtration (TFF) products that allow researchers to efficiently purify large volumes of protein-containing solutions that accelerate drug screening and improve sample preparation.